Apotheek Kachtem SRL
Apotheek Kachtem reported total assets of 127,170 € at the end of the 2025 financial year (annual accounts filed with the NBB on 17 Jun 2026).
The score of Apotheek Kachtem shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +202 % Total assets -61 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Apotheek Kachtem's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 73,884 € | ||||
| Equity | 113,775 € | ||||
| Cash | 21,402 € | ||||
| EBITDA | 115,459 € | ||||
| Total assets | 127,170 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 17 Jun 2026
- Year ended 31 Dec 2024filed on 23 Jun 2025
- Year ended 31 Dec 2023filed on 24 Jun 2024
- Year ended 31 Dec 2022filed on 09 Jun 2023
- Year ended 31 Dec 2021filed on 21 Jun 2022
Apotheek Kachtem's financial analysis
- Solvency89.5%sector median: 55.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Apotheek Kachtem
Apotheek Kachtem's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0632.575.404
- VAT number
- BE0632575404
- Peppol
- Registered · 0208:0632575404 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 18 Jun 2015
- Registered office
- 8870 Izegem
- Latest accounts
- 2025 · filed on 17 Jun 2026
- Activity
- Activities of holding companies (NACE 64210)
Apotheek Kachtem (SRL) has been based in Izegem since 2015, active in: activities of holding companies. For 2025, it reports a net profit of 73,884 € and equity of 113,775 €; its revenue is not published. Its solvency stands at 89.5%, above the median of its sector (55.6%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Apotheek Kachtem
Companies in the same business, of comparable size and area, outside its group.
- S&J Service Activities of holding companies Lille · balance sheet 126,181 €
- ED Merc Activities of holding companies Aalter · balance sheet 126,179 €
- Coach2Connect Activities of holding companies Turnhout · balance sheet 129,619 €
- GWGL Activities of holding companies Mol · balance sheet 124,327 €
- Vochten.com Activities of holding companies Zandhoven · balance sheet 124,293 €
- Creax Activities of holding companies Boechout · balance sheet 130,370 €
- Craeynest Finance Activities of holding companies Deinze · balance sheet 130,911 €
- Nooka Activities of holding companies Hasselt · balance sheet 123,161 €
Frequently asked questions about Apotheek Kachtem
What is the revenue of Apotheek Kachtem?
Apotheek Kachtem files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Apotheek Kachtem?
In Belgium, the VAT number is the company number prefixed with BE: BE0632575404 for Apotheek Kachtem, if the company is VAT-registered. Its company number (CBE) is 0632.575.404.
Where is the registered office of Apotheek Kachtem?
According to the CBE register, the registered office of Apotheek Kachtem is in 8870 Izegem.
What is the equity of Apotheek Kachtem?
At the close of the 2025 financial year, the equity of Apotheek Kachtem amounts to 113,775 €, a solvency of 89.5% of total assets.
Who manages Apotheek Kachtem?
The register lists 3 active mandates at Apotheek Kachtem. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Apotheek Kachtem
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →